跳至主要内容
临床试验/JPRN-jRCTs041180158
JPRN-jRCTs041180158已完成4 期

The investigation for the association between the choleretic effects of Inchinkoto and intestinal microenvironment in patients with obstructive jaundice

Yokoyama Yukihiro0 个研究点目标入组 54 人开始时间: 2019年3月29日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
54

研究概览

简要总结

sing metabolome analysis, we demonstrated several metabolic changes, such as serum aspartic acid level, that may be associated with the pharmacological mechanisms of ICKT. We also demonstrated the shape of gut microbiome before treatment might be associated with the activity and the efficacy of ICKT.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1)Patients with biliary stenosis.
  • 2)Patients with biliary drainage by percutaneous transhepatic biliary drainage or endoscopic nasal biliary drainage. At least 3 days after biliary drainage.
  • 3)Age over 20 years.
  • 4)Inhospital patients.
  • 5)Patients who can do oral intake.
  • 6)Patients who agree to participate in this study.

排除标准

  • 1)Patients with severe complications such as renal, cardiac, hematologic, and metabolic diseases.
  • 2)Patients who are taking Kampo within 4 weeks.
  • 3)Patients who are taking choleretic drug within 4 weeks.
  • 4)Patients who are participating or scheduled to participate in another trial.
  • 5)Patients in pregnant or who expect being pregnant.
  • 6)Patients who are allergic to Kampo.
  • 7)Patients who are not eligible for this study by investigators' decision.

研究者

发起方
Yokoyama Yukihiro

相似试验